Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cells in vitro and in vivo

Breast Cancer Research and Treatment

Volumn 39, Issue 2, 1996, Pages 147-154

  Rostagno, Philippe ^a   Moll, Jean Louis ^a   Birtwisle Peyrottes, Isabelle ^a   Ettore, Francette ^a   Caldani, Cyril ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Antiestrogen; Drug resistance; Image cytometry; Steroid receptor

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SURVIVAL; CELL CYCLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INTRAMUSCULAR DRUG ADMINISTRATION; LONG TERM CARE; MITOSIS; MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

EID: 0029811948     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806181     Document Type: Article

References (31)

1. Osborne CK, McGuire WL: Current use of steroid hormone receptor assays in the treatment of breast cancer. Surg Clin North Am 58: 777-788, 1978
2. Iino Y, Sugamata N, Maemura M, Takeo T, Owada S, Yokoe T, Ishikita T, Horiuchi R, Morishita Y: Intersite variation of estrogen receptors in human breast cancers and response to endocrine therapy - which section of a large tumor is the best for estrogen receptor assay? Oncology 49: 89-92, 1992
3. Dong XF, Berthois Y, Colomb E, Martin PM: Cell cyclephase dependence of estrogen and epidermal growth factor (EGF) receptor expression in MCF-7 cells: implications in antiestrogen and EGF cell responsiveness. Endocrinology 129: 2719-2728, 1991
4. Maas H, Jonat W, Stollzenbach G, Trams G: The problem of non-responding estrogen receptor positive patients with advanced breast cancer. Cancer 46: 2835-2837, 1980
5. Rostagno P, Caldani C, Lahlou B: Cell cycle expression of steroid receptors determined by image analysis on a human breast cancer cell line: a hypothesis on the effects of antiestrogens. Breast Cancer Res Treat, in press, 1995
6. Lippman ME, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595-4601, 1976
7. Walker KJ, McClelland RA, Candlish W, Blarney RW, Nicholson RI: Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. Eur J Cancer 28: 34-37, 1992
8. Osborne CK, Hobbs K, Clark GM: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584-590, 1985
9. Shafie SM, Grantham FH: Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67:51-56, 1981
10. Horwitz KB, McGuire WL: Nuclear mechanisms of estrogen action: effect of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Biol Chem 253: 8185-8191, 1978
11. Al Saati T, Clamens S, Cohen-Knafo E, Faye JC, Prats H, Coindre JM, Wafflart J, Caverivière P, Bayard F, Delsol G: Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 55: 651-654, 1993
12. Blaustein JD, Turcotte JC: Estradiol-induced progestin receptor immunoreactivity is found only in estrogen receptorimmunoreactive cells in guinea pig brain. Neuroendocrinology 49: 454-461, 1989
13. Rostagno P, Moll JL, Birtwisle-Peyrottes I, Ettore F, Lagrange JL, Gioanni J, Caldani C: Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling. Anticancer Res 14: 2025-2032. 1994
14. Galbraith W, Wagner MCE, Chao J, Abaza M, Ernst LA, Nederlof MA, Hartsock RJ, Taylor L, Waggoner AS: Imaging cytometry by multiparameter fluorescence. Cytometry 12: 579-596, 1991
15. Baisch H: Analysis of PCT-data to determine the traction of cells in the various phases of cell cycle. Rad Environ Biophys 12: 31-39, 1975
16. Cassanelli S, Guillaud P, Louis J, Seigneurin D: Image cytometry of progesterone receptor expression during the cell cycle in the MCF-7 cell line. J Histo Cyto 12: 1713-1718, 1991
17. Barsega R: Growth in size and cell DNA replication. Exp Cell Res 151: 1-5, 1984
18. Leroy F, Bogaert C, Van Hoeck J: DNA replication and accelerated chain growth in oestrogen-stimulated uterine cells. Nature 258: 259-260, 1975
19. Silvestrini R, Daidone MG, Bertizzi A: Relationship between estrogen receptors and cellular proliferation. Recent results. Cancer Res 91: 163-168, 1984
20. Sutherland RL, Green MD, Hall RE, Reddel RR, Taylor IW: Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle, Eur J Clin Oncol 19: 615-621, 1983
21. Butler WB, Kelsey WH, Goran N: Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res 41: 82-88, 1981
22. Sarkaria JN, Gibson DFC, Jordan VC, Fowler JF, Lindstrom MJ, Mulcahy RT: Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry. Cancer Res 53: 4413-4417, 1993
23. Gerschenson LE, Conner EA, Yang J, Anderssein M: Hormonal regulation of proliferation in two populations of rabbit endometrial cells in culture. Life Sci 24: 1337-1344, 1979
24. Paik S, Hartmann DL, Dickson RB, Lippman ME: Antiestrogen resistance in ER positive breast cancer cells. Breast Cancer Res Treat 31: 301-307, 1994
25. Sutherland RL, Reddel RR, Green MD: Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antiestrogens. Eur J Cancer Clin Oncol 19: 307-318, 1983
26. Gottardis MM, Jordan VC: Development of tamoxifenstimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res 48: 5183-5187, 1988
27. Katzenellenbogen BS: Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst 83: 1434-1435, 1941
28. Karnik PS, Kulkarni S, Liu XP, Budd GT, Bukowski RM: Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res 54: 349-353, 1994
29. Encarnacion CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SAW, Osbornc CK: Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res Treat 26: 237-246, 1993
30. Osborne CK, Fuqua SAW: Mechanisms of tamoxifen resistance. Breast Cancer Res Treat 32: 49-55, 1994
31. Osborne CK, Arteaga CL: Autocrinc and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Res Treat 15: 3-11, 1990